Document is current
Any future updates will be listed below
-
Authors
Nguyen, Binh An https://orcid.org/0000-0001-7055-8809
Singh, Virender https://orcid.org/0000-0002-6720-8784
Afrin, Shumaila
Singh, Preeti https://orcid.org/0000-0003-2508-5613
Pekala, Maja
Ahmed, Yasmin
Pedretti, Rose
Canepa, Jacob
Lemoff, Andrew https://orcid.org/0000-0002-4943-0170
Kluve-Beckerman, Barbara
Wydorski, Pawel M. https://orcid.org/0000-0002-6983-421X
Chhapra, Farzeen
Saelices, Lorena https://orcid.org/0000-0002-1904-2150
-
Funding
Funding for this research was provided by:
American Heart Association (847236)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (DP2-DL163810)
Welch Foundation (I-2121-20220331)
- License Information
-
More Information
Article History
Received: 7 May 2024
Accepted: 15 July 2024
First Online: 27 July 2024
Competing interests
: L.S. consults for Intellia Therapeutics Inc. and Attralus Inc., and Advisory Board member for Alexion Pharmaceuticals. The remaining authors declare no competing interests.
